The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
It's a shame I don't have access to a Bloomberg terminal as that will show who owns what on the Shareholdings page from the Security Description. I seem to think Jarvis have quite a big holding but their holding will be at an omnibus level and probably has a lot of 'individual' holders of varying size within it.
Cheeky - Stockbroker IS a proper job...
Gave it a try - I’m a Seahorse! Seems pretty good for me. I remember having to go to the careers office in the 1980s just after they’d invented the first ‘careers’ programme. I had to answer a lot of questions which were fed into the computer. A lot of effort later I got a print out from the computer on that green music paper that computers used then and my ideal job was ‘Careers Advisor’. I asked the carreers advisor if there were any jobs going and he said ‘No.’ I then went to work for a firm of stockbrokers.
FYI - According to Morning Star - 67% of the shares are in the hands of 2 holders. The total issue (also according to the Total Voting Rights RNS Announcement in January is 373,300,000 - so it looks like the ‘tradable amount is’ 33% which would be 123,189,000.
Everyone who took these in the placing either bought them at 0.75p and hopes to make a profit or sold them last week at higher levels and will cover at 0.75. Either way I think these have limited downside and have doubled my position today.
http://tools.morningstar.co.uk/uk/stockreport/default.aspx?tab=5&vw=own&SecurityToken=0P00007Z2O%5D3%5D0%5DE0WWE%24%24ALL&Id=0P00007Z2O&ClientFund=0&CurrencyId=GBP These are the biggest shareholders. I would imagine that Yahoo is looking at the likes of TDW and Hargraeves Landsdown etc as ‘institutions’ when companies/brokers like that hold these in a single account for all their PIs. If anyone has a decent holding they MUST declare it so it pretty much looks like most holders are NOT institutional at this time.
No - they want holders to waive their pre-emptive rights. If the vote is successful they can issue new shares via placings and NOT offer them to existing holders.
See Sierra closed at $3.45 - ‘Can’t Keep a good stock down’ as we used to say....
Looks more like a chronic lack of interest. Vol of 2.5m is only £20,000 a day in trades and with a 0.07 max spread - the jobbers/MMs only making £1,750 on this today so far. Any news and any decent buying volume will move these but at the moment there is little interest and they’re just ticking over. Sierra are much more popular right now however.
I sold half my SAR @ 0.08 and bought SRRA @ 2.01 in April. It won’t be long now before I can sell SRRA and buy more SAR back as they’ve been flat the whole time.
Does anyone know if YA are fully out now or if they still have a holding to sell?
The reason is that the price displayed is the ‘touch’ this is where the Best Bid and Best Offfer meet. Let’s say the spread is 10p. If one Market Maker has 1.20 bid and 1.30 offer and another has 1.25 bid and 1.35 offer the ‘touch’ best bid and best offer are 1.25 - 1.30. In real life there are many more market makers and the touch moves as they compete. If one is at 1.29 - 1.39 and another 1.20 - 1.30 the touch is down to 1 at 1.29 - 1.30. Hope that explains things.
The Security has a single share listing on AIM - Price £1.43 to £1.50 at present. There is an American Depositary Receipt (representing 8 UK shares - 8 x £1.43 = £11.45) traded on NASDAQ. Each ADR (or ADS as they are sometimes referred to) is a US Certificate representing shares im the UK on the VRP share register. The ADRs are traded in USD - last night close was $15.60 which at an exchange rate of 1.30 is the equivalent of £1.50 per AIM share. The Market Makers will try to keep then in sync as they have the ability to create new ADRs using AIM shares to sell on NASDAQ or split up ADRs in the US and deliver to AIM to sell to UK holders. If the price diverges too much traders will also try to arbitrage these - buying on one market and selling on another. If this can be done in enough size a reasonable return can be made arbitraging. That's it in a nutshell. If there is excessive US demand traders here will create new ADRs using shares sold on AIM to sell on to US buyers.
Just had a quick look on Bloomberg and the Depositary Receipt Data confirms that 1 ADR = 8 shares. These will be ADRs and not ADS. I have been in these since the 15p (£7.50 at 50-1 rate) so am watching this with interest.
I see these are €0.04 bid in Frankfurt (Symbol A0HG7U) but languishing at 3p bid here. Looks like there is a bit of trading on other markets.
Have been in these since the 15p days and have a strong belief that the treatment will be a great thing if and when it comes to market. Have averaged down over the last few years and am looking forward to this taking off. Recent developments suggest that VRP is on the move again and a NASDAQ presence will also be a good thing.
The trade of 65,500 was a buy as it was mine and the 75,000 after was probably a sell as the price was 3.3 - 3.4 at the time. There is no requirement at the LSE to say if a trade is a buy or a sell and so it's always best guess.
Actually - it says at the bottom Wales has 8.1% and Arix Bioscience has 2.5% so it's no change from the 8.09 on Morningstar which must be up to date. Still a sizeable holding however....
The post placing holding declarations are coming thick and fast. It will be interesting to see how these all add up when completed but good to see that it looks like Wales Life Fund moved from 8.09% (Morningstar) to 10.6% of the enlarged share capital and a few others with decent holdings joining the party.
These reports look like officical notification of holdings following the approval of the placing and issue of new shares on Friday. As the number of shares has increased you would expect to see existing large holders perecentages decrease if the hadn't taken any new shares in the placing so as these looks like upward movements it's most likely these are the placing participants declaring their positions following the change to the number of shares in issue.